logo-large
  • Browse Categories

Publications by authors named "Michael Rotkis"

Claim this Profile
P
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Peter Beitsch, Pat Whitworth, Paul Baron, Michael C Rotkis, Angela M Mislowsky

Ann Surg Oncol· September 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
Pat Whitworth, Peter Beitsch, Angela Mislowsky, James V Pellicane, Charles Nash, Michael Rotkis

Ann Surg Oncol· March 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, Paul Richards, Michael Rotkis

Ann Surg Oncol· October 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: